api 1 680622 70 2 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
93
Structured Review
MedChemExpress
api 1 680622 70 2
Api 1 680622 70 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/api+1/API-1/pm39985265-331-0-9
Average 93 stars, based on 2 article reviews
Api 1 680622 70 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/api+1/API-1/pm39985265-331-0-9
Average 93 stars, based on 2 article reviews
api 1 680622 70 2 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
other:Article Title: CpG‐Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2‐Mediated Remodeling of Tumor‐Associated Macrophages Article Snippet: API‐1(680622‐70‐2) and Article Title: CpG-Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2-Mediated Remodeling of Tumor-Associated Macrophages. Article Snippet: API-1(680622-70-2) and Article Title: Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation ― Findings From the SAKURA AF Registry ― Article Snippet: Incidence of Major Clinical Events During the 2-Year Follow-up Among WF vs. DOAC Users and Among WF vs. DA, Riv and Api Users WF (n=1,561) DOAC (n=1,676) Crude HR (DOAC vs. WF) DA (n=456) MCE (%) at 1 year MCE (%) at 2 years MCE (%) at 1 year MCE (%) at 2 years MCE (%) at 1 year MCE (%) at 2 years Stroke or SE 1.8 (1.2–2.5) 2.8 (2.1–3.7) 1.2 (0.7–1.8) 2.9 (2.2–3.9) 1.15 (0.82–1.62) 1.2 (0.5–2.7) 2.1 (1.1–3.9) Intracranial hemorrhage 0.5 (0.3–1.0) 0.8 (0.5–1.4) 0.1 (0.03–0.5) 0.8 (0.5–1.4) 1.03 (0.57–1.87) 0.2 (0.03–1.6) 0.2 (0.03–1.6) Major bleeding 1.2 (0.7–1.9) 2.4 (1.7–3.3) 0.5 (0.3–1.1) 2.2 (1.6–3.1) 0.90 (0.63–1.28) 0.4 (0.1–1.8) 1.6 (0.8–3.4) All-cause death 1.7 (1.1–2.5) 3.6 (2.7–4.6) 2.1 (1.5–2.9) 3.9 (3.0–5.0) 0.87 (0.66–1.15) 2.2 (1.2–4.1) 4.5 (2.9–6.9) Composite net clinical events 3.6 (2.8–4.7) 6.7 (5.5–8.1) 3.5 (2.7–4.5) 7.6 (6.4–9.0) 0.95 (0.77–1.16) 3.1 (1.8–5.1) 6.7 (4.9–9.7) Crude HR (DA vs. WF) Riv (n=761) Crude HR (Riv vs. WF) Api (n=428) Crude HR ( |